Jingyu Zhang
Tianjin University of Technology and Education(CN)Nanchang University(CN)Shandong University(CN)University of Pittsburgh(US)Zhejiang Cancer Hospital(CN)Second Affiliated Hospital of Nanchang University(CN)Drug Discovery Laboratory (Norway)(NO)Shenyang The Fourth Hospital of People(CN)Weihai Science and Technology Bureau(CN)Hangzhou Cancer Hospital(CN)Inner Mongolia University of Technology(CN)Zhejiang University(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, RNA modifications and cancer, Protein Degradation and Inhibitors, Cell Adhesion Molecules Research, Ubiquitin and proteasome pathways
Most-Cited Works
- → Breast cancer prognosis signature: linking risk stratification to disease subtypes(2018)114 cited
- → Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α(2021)72 cited
- → Long non-coding RNA NEAT1 promotes colorectal cancer progression by regulating miR-205-5p/VEGFA axis(2020)56 cited
- → Structural Feature Analyzation Strategies toward Discovery of Orally Bioavailable PROTACs of Bruton’s Tyrosine Kinase for the Treatment of Lymphoma(2022)51 cited
- → Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation(2018)48 cited
- → YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway(2019)37 cited